EP Patent

EP4704853A1 — Method of treating operative complications of cataract surgery

Assigned to Formosa Pharmaceuticals Inc · Expires 2026-03-11 · 0y expired

What this patent protects

The present disclosure provides a method of treating or ameliorating an operative complication of a cataract surgery. The method comprises administering nanoparticles of clobetasol propionate to a subject in need thereof.

USPTO Abstract

The present disclosure provides a method of treating or ameliorating an operative complication of a cataract surgery. The method comprises administering nanoparticles of clobetasol propionate to a subject in need thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP4704853A1
Jurisdiction
EP
Classification
—
Expires
2026-03-11
Drug substance claim
No
Drug product claim
No
Assignee
Formosa Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.